All Videos Tagged cancer (MedTech I.Q.) - MedTech I.Q.

Informatics: Obstacles to Unlocking the Human Genome

2009-06-29T14:22:58.320Z

A panel of DNA, policy, and research experts analyze the social implications of pharmaceutical companies and universities patenting the human genome. Ballon compares the argument against releasing genetic information to a 1961 study of cancer diagnosis.

-----

Personal genomic testing (the analysis of the DNA of individuals) is now available for less than $400. The consequences of personal genetic testing are often debated, with advocates arguing that genetic data can lead to improved health care and critics warning that consumers may be unduly worried upon learning results.

California regulations impose conditions on firms providing personal genomic testing. This symposium examines genomic testing technology, its ramifications, government regulation of the industry, and whether individuals should have their genome analyzed. - Commonwealth Club of California

Linda Avey has over 20 years of sales and business development experience in the biopharmaceutical industry in San Francisco, Boston, San Diego, and Washington, D.C. Prior to starting 23andMe, she developed translational research collaborations with academic and pharmaceutical partners for Affymetrix and Perlegen Sciences. Avey also spent time at Spotfire helping scientists understand the power of data visualization and at Applied Biosystems during the early days of the human genome project. The advent of high density genome-wide scanning technologies brought huge potential for significant discoveries. However, the lack of sufficient funding to enable adequate studies prompted Avey to think of a new research model. These ideas led to the formation of 23andMe. Her primary interest is the acceleration of personalized medicine, using genetic profiles to target the right drug to the right person at the correct dose. Avey graduated from Augustana College with a B.A. in biology.

Daniel Ballon is Senior Policy Fellow in Technology Studies at the Pacific Research Institute. Dr. Ballon's research focuses on policies which promote innovation in the technology sector. He previously spent ten years conducting applied research in biotechnology, and his work has been published in leading biomedical journals. Prior to joining PRI, he served as science and technology policy advisor for former Speaker of the House Newt Gingrich at the American Enterprise Institute. Dr. Ballon received his Ph.D. in Molecular and Cell Biology from the University of California at Berkeley and a B.A. in Molecular Biology and Biochemistry from Wesleyan University.

David C. Magnus, Ph.D. is Associate Professor of Pediatrics and Medicine, Stanford University. Magnus is also Director of the Stanford Center for Biomedical Ethics.

Strategy: Obama Team Leverages Second Life

2009-01-25T17:28:08.643Z

The Obama/Biden team is using new technology to the fullest: online organizing through their website & Facebook are standard. But the goal of citizen engagement could be helped tremendously using virtual worlds such as Second Life. Now the healthcare transition team sanctioned an experiment: Draxtor Despres recently participated in a community discussion on healthcare and looked at the potential of using virtual worlds to enhance citizen participation in healthcare reform.

Telemedicine: Teledermatology in Brazil - Early Skin Cancer Detection

2009-01-25T15:13:05.652Z

This video describes the Teledermatology Project being performed by the Cyclops Group at the Santa Catarina State Telemedicine Network. It aims at the early detection of various types of skin cancer in isolated communities, mainly fishermen villages, in the southern Brazil coastal area. The project provides digital dermatoscopy and computer equipment to Primary Healthcare Units and offers dermatologists assessment services in a web-based network. People can perform their dermatoscopic examinations at the local Primary Healthcare Unit and their local doctors access the findings report via the Telemedicine Portal. Patients presenting are suspect lesions are sent to a regional hospital for biopsy and treatment.
Visit: http://cyclops.telemedicina.ufsc.br/

Surgical Robotics: Robotic prostatectomy is becoming more common for early stage prostate cancer

2008-08-13T17:39:51.151Z

Professor Tony Costello and Mr Declan Murphy present an overview of robotic-assisted surgery for prostate cancer at Epworth Hospital in Melbourne, Australia. Aimed at patients and GPs, this short video explains the technology behind robotic surgery for prostate cancer.
Epworth Hospital, http://www.epworth.org.au/Main-Site/Home.aspx?server=org

Regenerative Medicine: In Memoriam - Judah Folkman, MD, A Giant of Cancer Therapy

2008-08-02T15:16:06.726Z

In this MedScape video, Dr Dov Michaeli, MD, PhD, CEO, Madah Medica, California, eulogizes his mentor, the father of angiogenesis study, Judah Folkman. MedScape, http://www.medscape.com/home